Autosomal dominant Parkinson's disease caused by SNCA duplications
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The discovery in 1997 that mutations in the SNCA gene cause Parkinson’s disease (PD) greatly advanced our understanding of this illness. There are pathogenic missense mutations and multiplication mutations in SNCA. Thus, not only a mutant protein, but also an increased dose of wild-type protein can produce autosomal dominant parkinsonism. We review the literature on SNCA duplications and focus on pathologically-confirmed cases. We also report a newly-identified American family with SNCA duplication whose proband was autopsied. We found that over half of the reported cases with SNCA duplication had early-onset parkinsonism and non-motor features, such as dysautonomia, rapid eye movement sleep behavior disorder (RBD), hallucinations (usually visual) and cognitive deficits leading to dementia. Only a few cases have presented with typical features of PD. Our case presented with depression and RBD that preceded parkinsonism, and dysautonomia that led to an initial diagnosis of multiple system atrophy. Dementia and visual hallucinations followed. Our patient and the other reported cases with SNCA duplications had widespread cortical Lewy pathology. Neuronal loss in the hippocampal cornu ammonis 2/3 regions were seen in about half of the autopsied SNCA duplication cases. Similar pathology was also observed in SNCA missense mutation and triplication carriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citation(2004) · doi:10.1002/ana.10846 · Cited by 614 · cited 1×
“In addition, the neuronal loss in the CA2/3 region was observed in two cases, which is typical of SNCA mutation carriers [25,26] and distinct from neuronal loss in CA1, which is usually associated with TDP-43 pathology [26,27].”
BackgroundPhenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication
Fuchs, J., Nilsson, C., Kachergus, J., Munz, M., Larsson, E.-M., Schüle, B., Langston, J. W., Middleton, F. A., Ross, O. A., Hulihan, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000254458.17630.c5 · Cited by 397 · cited 4×
“Interestingly, it is known that a Swedish family with SNCA duplication and a Swedish American family with triplication were descended from a common ancestor [15].”
BackgroundInfluentialSelf-citationGenomic investigation of α‐synuclein multiplication and parkinsonism
Ross, O. A., Braithwaite, A. T., Skipper, L. M., Kachergus, J., Hulihan, M. M., Middleton, F. A., Nishioka, K., Fuchs, J., Gasser, T., Maraganore, D. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21380 · Cited by 342
Self-citationClinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease
Nishioka, K., Hayashi, S., Farrer, M. J., Singleton, A. B., Yoshino, H., Imai, H., Kitami, T., Sato, K., Kuroda, R., Tomiyama, H., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20753 · Cited by 316
The neuropathology of genetic Parkinson's disease
Poulopoulos, M., Levy, O. A., & Alcalay, R. N. (2012) · Movement Disorders · doi:10.1002/mds.24962 · Cited by 311 · cited 1×
“There was marked depigmentation and neuronal loss in the substantia nigra and locus ceruleus, neuronal loss in the basal nucleus of Meynert and the dorsal motor nucleus of the vague nerve, widespread Lewy bodies (LBs) from the brainstem to the neocortex [22], and Lewy neurites in the cornu ammonis (CA) 2/3 region, ori…”
BackgroundDickson, D. W., Ruan, D., Crystal, H., Mark, M. H., Davies, P., Kress, Y., & Yen, S.-H. (1991) · Neurology · doi:10.1212/wnl.41.9.1402 · Cited by 295 · cited 1×
“There was marked depigmentation and neuronal loss in the substantia nigra and locus ceruleus, neuronal loss in the basal nucleus of Meynert and the dorsal motor nucleus of the vague nerve, widespread Lewy bodies (LBs) from the brainstem to the neocortex [22], and Lewy neurites in the cornu ammonis (CA) 2/3 region, ori…”
BackgroundSelf-citationα-Synuclein gene duplication is present in sporadic Parkinson disease
Ahn, T. B., Kim, S. Y., Kim, J. Y., Park, S. S., Lee, D. S., Min, H. J., Kim, Y. K., Kim, S. E., Kim, J. M., Kim, H. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000271080.53272.c7 · Cited by 249 · cited 1×
“The third case developed dementia after DBS procedure [8].”
BackgroundPuschmann, A. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.01.020 · Cited by 238 · cited 1×
“Twenty-one PARK loci have been identified for familial PD, including autosomal dominant, autosomal recessive, and X-linked forms, and causative genes have been discovered for a majority of them [2].”
BackgroundSelf-citationIbáñez, P. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.555 · Cited by 152
Expanding the clinical phenotype of SNCA duplication carriers
Nishioka, K., Ross, O. A., Ishii, K., Kachergus, J. M., Ishiwata, K., Kitagawa, M., Kono, S., Obi, T., Mizoguchi, K., Inoue, Y., et al. (2009) · Movement Disorders · doi:10.1002/mds.22682 · Cited by 136 · cited 1×
“Genetic counselling is made difficult by the wide range of ages at which symptoms develop in SNCA duplication carriers, and by the fact that penetrance remains incomplete even at 79 years of age [20].”
BackgroundSelf-citationGenetics of Parkinson's disease: the yield
Spatola, M., & Wider, C. W. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70011-7 · Cited by 133 · cited 1×
“Introduction Approximately 10% of patients with Parkinson’s disease (PD) report a positive family history [1].”
BackgroundPatients Homozygous and Heterozygous for SNCA Duplication in a Family With Parkinsonism and Dementia
Ikeuchi, T., Kakita, A., Shiga, A., Kasuga, K., Kaneko, H., Tan, C.-F., Idezuka, J., Wakabayashi, K., Onodera, O., Iwatsubo, T., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.514 · Cited by 130 · cited 2×
“Symptomsmanifested at 28 years in the Japanese patient with four SNCA copies, versus at 57 (mean, n 1⁄4 3, SD: 16, range 39e71) years in family members with three copies [9].”
BackgroundUpdate on novel familial forms of Parkinson's disease and multiple system atrophy
Fujioka, S., Ogaki, K., Tacik, P. M., Uitti, R. J., Ross, O. A., & Wszołek, Z. K. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70010-5 · Cited by 120 · cited 1×
“Gly51Asp [5]) and gene multiplications (genomic duplications and triplications) have been reported in SNCA.”
BackgroundSelf-citationClinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease
Markopoulou, K., Dickson, D. W., McComb, R. D., Wszołek, Z. K., Katechalidou, L., Avery, L. L., Stansbury, M. S., & Chase, B. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0372-4 · Cited by 118
Self-citationSharma, M., Ioannidis, J. P. A., Aasly, J. O., Annesi, G., Brice, A., Bertram, L., Bozi, M., Barcikowska, M., Crosiers, D., Clarke, C. E., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101155 · Cited by 107 · cited 1×
“The pathogenicity of SNCA, LRRK2 and VPS35 mutations is established beyond a doubt from many observations, even though the penetrance of some of the mutations in these genes is incomplete [3].”
BackgroundSelf-citationHippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A
Aoki, N., Murray, M. E., Ogaki, K., Fujioka, S., Rutherford, N. J., Rademakers, R., Ross, O. A., & Dickson, D. W. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1358-z · Cited by 89 · cited 1×
“In addition, the neuronal loss in the CA2/3 region was observed in two cases, which is typical of SNCA mutation carriers [25, 26] and distinct from neuronal loss in CA1, which is usually associated with TDP-43 pathology [26, 27].”
BackgroundSelf-citationCLINICOPATHOLOGIC STUDY OF A SNCA GENE DUPLICATION PATIENT WITH PARKINSON DISEASE AND DEMENTIA
Obi, T., Nishioka, K., Ross, O. A., Terada, T., Yamazaki, K., Sugiura, A., Takanashi, M., Mizoguchi, K., Mori, H., Mizuno, Y., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000299387.59159.db · Cited by 85 · cited 1×
“This patient also had MIBG myocardial scintigraphy that showed a reduced H/M ratio, indicating cardiac sympathetic denervation [19].”
BackgroundSelf-citationKara, E., Kiely, A. P., Proukakis, C., Giffin, N., Love, S., Hehir, J., Rantell, K. R., Pandraud, A., Hernandez, D. G., Nacheva, E. P., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.994 · Cited by 73 · cited 1×
“The parkinsonism associated with this case appeared at age 38 years [21].”
BackgroundClinical Features of Familial Diffuse Lewy Body Disease
Ishikawa, A., Takahashi, H., Tanaka, H., Hayashi, T., & Tsuji, S. (2008) · European Neurology · doi:10.1159/000113459 · Cited by 45
Cardiac sympathetic denervation in Parkinson’s disease linked to SNCA duplication
Orimo, S., Uchihara, T., Nakamura, A., Mori, F., Ikeuchi, T., Onodera, O., Nishizawa, M., Ishikawa, A., Kakita, A., Wakabayashi, K., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0428-5 · Cited by 43 · cited 1×
“Pathology in epicardial autonomic nerves was observed in three cases [29].”
BackgroundAutosomal dominant diffuse Lewy body disease
Wakabayashi, K., Hayashi, S., Ishikawa, A., Hayashi, T., Okuizumi, K., Tanaka, H., Tsuji, S., & Takahashi, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050883 · Cited by 42
Fujishiro, H., Imamura, A., Lin, W.-L., Uchikado, H., Mark, M. H., Golbe, L. I., Markopoulou, K., Wszołek, Z. K., & Dickson, D. W. (2013) · Europe PMC (PubMed Central) · Cited by 39
Self-citationα-Synuclein gene duplication is present in sporadic Parkinson disease
Brueggemann, N., Odin, P., Gruenewald, A., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000338439.00992.c7 · Cited by 36 · cited 1×
“The third case developed dementia after DBS procedure [8].”
BackgroundYoung‐onset parkinsonism due to homozygous duplication of α‐synuclein in a consanguineous family
Kojović, M., Sheerin, U., Rubio‐Agusti, I., Saha, R. A., Brás, J., Gibbons, V., Palmer, R. W., Houlden, H., Hardy, J., Wood, N. W., et al. (2012) · Movement Disorders · doi:10.1002/mds.25199 · Cited by 27
A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure
Guerrero, R., Ruiz, P., Giráldez, B. G., Durán-Herrera, C., Querol‐Pascual, M. R., Serratosa, J. M., Mas, S., & Serratosa, J. M. (2012) · Movement Disorders · doi:10.1002/mds.25114 · Cited by 24
Cited by
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
Rocha, E. M., De Miranda, B., & Sanders, L. H. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.004 · Cited by 762
The genetics of Parkinson disease
Deng, H., Wang, P., & Jankovic, J. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.007 · Cited by 530
Visual dysfunction in Parkinson’s disease
Weil, R. S., Schrag, A. E., Warren, J. D., Crutch, S. J., Lees, A. J., & Morris, H. R. (2016) · Brain · doi:10.1093/brain/aww175 · Cited by 481
“Patients with Parkinson’s disease carrying mutations in the gene for synuclein, SNCA, also show higher rates of cognitive deficits, REM sleep behaviour disorder (RBD) and hallucinations (Nishioka et al., 2009; Konno et al., 2016; Petrucci et al., 2016).”
BackgroundDeterminants of dopaminergic neuron loss in Parkinson's disease
Surmeier, D. J. (2018) · The FEBS Journal · doi:10.1111/febs.14607 · Cited by 444
Metadata
- Authors
- Konno, T., Ross, O. A., Puschmann, A., Dickson, D. W., & Wszolek, Z. K.
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 22
- Pages
- S1-S6
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W2145147096
- Cited by
- 210
- References
- 27
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.